Basiliximab Versus Rabbit Anti-thymocyte Globulin for Induction Therapy in Patients After Heart Transplantation
- 1 November 2006
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 25 (11), 1358-1362
- https://doi.org/10.1016/j.healun.2006.09.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Comparison of Basiliximab and Anti-Thymocyte Globluin as Induction Agents After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2005
- A Multicenter, Prospective, Randomized, Double-Blind Trial of Basiliximab in Heart TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Monitoring of Cyclosporine 2-Hour Post-Dose Levels in Heart Transplantation: Improvement in Clinical OutcomesThe Journal of Heart and Lung Transplantation, 2005
- Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejectionThe Journal of Heart and Lung Transplantation, 2005
- Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunctionThe Journal of Heart and Lung Transplantation, 2005
- Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipientsLiver Transplantation, 2004
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- Should moderate acute rejection of a cardiac transplant graft be treated?Clinical Transplantation, 2002
- Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrationsTransplant Immunology, 2001
- Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart InstituteTransplantation Proceedings, 1997